113 Botanicals Launches £2m Raise to Bring Controlled-Release Cannabis Capsule to UK Patients
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
24 results for “uk-patients”
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
Healthcare professionals attending the Cannabis Health Symposium next month will be able to earn CPD points to support their professional development. The Cannabis Health Symposium is a Continuing Professional Development […]
The report highlights ‘concerns’ over the lack of NHS access, but does not support further reform to cannabis laws.
Head grower at Dalgety, Brady Green, explores the difference between prescribed cannabis and its illegal counterpart.
Hemp leaves, when separate from the flower, are now no longer classed as a Novel Food in the EU.
Reports include patients being labelled as ‘drug addicts’, refused help and referred to social services after disclosing that they use cannabis medicinally.
Only a tiny fraction of UK medical cannabis patients are accessing the legal market. Why is that and what do we do about it?
It’s time to de-schedule, de-penalise and decriminalise all cannabis offences, writes activist Simpa Carter.
Today Black people are still disproportionately targeted by cannabis laws, but how did these policies evolve?
The new facility will ‘improve security of supply’ and meet demand from patients across Europe.
From groundbreaking studies to patient perspectives, here’s what happened in the world of UK cannabis (and beyond) in 2022
The medicine Oliver Rice has relied on to keep him well, will no longer be available in the UK from the end of the year.
The move is intended to improve patient access by supplying cannabis-based medicines produced in the UK.
Industry leaders believe it would streamline the process of making cannabis medicines more widely available.
Patients are still experiencing issues related to supply, cost, quality and stigma four years on from the law change.
Rachel Rankmore and Craig Williams, will join experts in Cardiff on Wednesday.
Patients prescribed cannabis for severe epilepsy will now have access to a UK supply of the Dutch oils.
The move is expected to see the creation of a European cannabis powerhouse.
Lyphe Group, the company behind The Medical Cannabis Clinics, has opened its doors down under.
The Medical Cannabis Clinicians Society has published guidance for CBD consumers.
60 per cent of respondents also said they would consider cannabis as an alternative to traditional medicine.
All the latest cannabis headlines in one place.
Members of the House of Lords discussed the barriers to access in the UK
UK patients will be able to access the medical cannabis oil Celixir20 until the end of the year.